MarginsXMarginsX
Home › Markets › Health Care › ACH

Accendra Health Inc. (ACH)

ACH trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.0857
-35.08% on the day
Market cap
$6.6M
Nano cap
Revenue · 2025
$2.8B
+3.1% on 2024
Net income · 2025
-$1.1B
-39.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/75252/000110465926018169/0001104659-26-018169-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerACH on NYSE
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000075252
SEC industry codeWholesale-Medical, Dental & Hospital Equipment & Supplies
Incorporated inVA

Financials · 2025

LineValue
Revenue$2.8B
Net income-$1.1B
Operating income$27.5M
Net margin-39.8%
Operating margin1.0%
Revenue growth+3.1%
Cash$282.0M
Total assets$2.5B
P/E (computed)Net income was not positive
P/S (computed)0.0×

Warning signs

Cash runway
12.6 months
$26.6M cash at September 30, 2026
Share count, 1 year
-0.5%
2025-10-24 to 2026-09-30 · +0.6% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$26.6M cash; operating cash flow -$6.3M a quarter.Report 2026-09-30
Shares outstanding76,924,334 (2026-09-30); 77,346,594 a year earlier; 76,501,043 three years earlier.Cover page 2026-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-07-15
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-10-30
AuditorKPMG LLP, Richmond, Virginia, United StatesPCAOB Form AP 2026-03-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$601.8M-$19.7M-$17.4M$26.6M$1.8B$2.6B10-Q 2026-11-06
Q2 2026
2026-06-30
$613.2M-$89.1M-$26.0M$7.7M$1.7B$2.6B10-Q 2026-08-10
Q1 2026
2026-03-31
$627.8M-$6.5M-$50.1M$336.9M$2.1B$2.7B10-Q 2026-05-11
Q4 2025
2025-12-31
$709.0M-$56.3M$68.2M$282.0M$2.0B$2.8B10-K 2026-02-20
Q3 2025
2025-09-30
$697.3M-$150.3M-$172.5M$32.8M$2.1B$2.7B10-Q 2026-11-06
Q2 2025
2025-06-30
$681.9M-$869.1M$37.6M$38.3M$2.0B$2.7B10-Q 2026-08-10
Q1 2025
2025-03-31
$673.9M-$25.0M-$35.1M$59.4M$1.9B$2.7B10-Q 2026-05-11
Q4 2024
2024-12-31
$695.0M-$296.1M$71.0M$27.6M$1.8B$4.7B10-K 2026-02-20

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-07-15
Latest annual report10-K2026-02-20
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-11-05
Latest proxyDEF 14A2026-10-29

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-35.0%
1 month-59.4%
3 months-88.2%
Year to date-95.4%
1 year-95.6%
From 52-week high-96.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
AMSAmerican Shared Hospital Services$1.07-0.93%$7.1M
ACONAclarion Inc.$1.39-12.58%$4.0M
ADVBAdvanced Biomed Inc.$2.22-12.25%$3.7M
MDXHMDxHealth SA$0.1490+3.40%$14.2M
BGLCBioNexus Gene Lab Corp$0.8200-0.12%$2.4M
SERASera Prognostics Inc.$1.94-3.48%$77.2M
XGNExagen Inc.$3.77-8.72%$96.2M
BDSXBiodesix Inc.$9.00-8.91%$99.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier